Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK1 | P19367 | 2/20 | 0.41 |
| ▸ | HK2 | P52789 | 2/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.39 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.39 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.39 |
| ▸ | PYGL | P06737 | 2/20 | 0.38 |
| ▸ | PYGB | P11216 | 2/20 | 0.38 |
| ▸ | PYGM | P11217 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10771475 | 0.81 | LGALS9 (0.39) | HK1HK2LGALS9LGALS1LGALS3 | |
| SCHEMBL27936287 | 0.79 | PYGB (0.44) | PYGLPYGBPYGM | |
| SCHEMBL6131050 | 0.78 | PYGB (0.43) | PYGLPYGBPYGM | |
| SCHEMBL27798338 | 0.77 | LGALS9 (0.40) | HK1HK2LGALS9LGALS1LGALS3 | |
| SCHEMBL14674782 | 0.76 | SLC5A2 (0.41) | — | |
| SCHEMBL30843273 | 0.76 | LGALS9 (0.40) | HK1HK2LGALS9LGALS1LGALS3 | |
| SCHEMBL3839216 | 0.75 | LGALS9 (0.38) | HK1HK2LGALS9LGALS1LGALS3 | |
| SCHEMBL3232264 | 0.74 | PYGB (0.50) | PYGLPYGBPYGM | |
| SCHEMBL7454320 | 0.74 | PYGB (0.43) | PYGLPYGBPYGM | |
| SCHEMBL31680369 | 0.74 | LGALS9 (0.37) | HK1HK2LGALS9LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166957-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | National Research Council of Canada (CA) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016004512-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2016-01-14 | — | — | WO | disclosed |